Table 3:
age group (years) | PCR test performed | Odds Ratio [CI] | P value | Adjusted odds Ratio [CI]* | |||||
---|---|---|---|---|---|---|---|---|---|
≥ 146 days since vaccine | < 146 days since vaccine | ||||||||
nb patients positive | nb patients tested | % positive | nb patients positive | nb patients tested | % positive | ||||
age 18–39 | 72 | 3,590 | 2.0% | 113 | 9,720 | 1.2% | 1.740 [1.273,2.365] | <0.001 | 1.67 [1.21,2.29] |
age 40–59 | 167 | 6,600 | 2.5% | 55 | 4,898 | 1.1% | 2.286 [1.672,3.167] | <0.001 | 2.22 [1.62,3.08] |
age ≥ 60 | 182 | 7,021 | 2.6% | 19 | 2,164 | 0.9% | 3.004 [1.863,5.118] | <0.001 | 2.76 [1.62–3.08] |
all | 421 | 17,211 | 2.4% | 187 | 16,782 | 1.1% | 2.225 [1.866,2.661] | <0.001 | 2.06 [1.69,2.51] |
Adjusted odds ratio are adjusted for age group, sex, socio-economic status (SES), ethnic group, and comorbidity factors (diabetes mellitus, hypertension, asthma, chronic obstructive pulmonary disease, ischemic heart disease, presence of malignancy, and chronic kidney disease) as covariates.